HighTower Advisors
INSM icon

HighTower Advisors’s Insmed INSM Stock Holding History

HighTower Advisors’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$637K Buy
3,897
+861
+28% +$132K ﹤0.01% 2518
2025
Q4 		$528K Buy
3,036
+349
+13% +$63.7K ﹤0.01% 2572
2025
Q3 		$387K Buy
2,687
+535
+25% +$65.5K ﹤0.01% 2824
2025
Q2 		$217K Buy
+2,152
New +$165K ﹤0.01% 3212

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

HighTower Advisors's INSM Position: Q1 2026 in Review

HighTower Advisors increased its Insmed (INSM) stake by 28% in Q1 2026, buying an estimated $132K and bringing the position to 3,897 shares worth $637K. The position accounts for ﹤0.01% of the portfolio, ranked #2518.

HighTower Advisors first reported a position in INSM in Q2 2025 and has held it in 4 quarters since. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • HighTower Advisors held 3,897 shares of Insmed worth $637K as of Q1 2026.
  • HighTower Advisors bought 861 Insmed shares in Q1 2026, an estimated $132K.
  • Insmed made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #2518 holding.
  • HighTower Advisors first reported a position in Insmed in Q2 2025 and has held it in 4 quarters since.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.